Evaluation of rapamycin chemical stability in volatile-organic solvents by HPLC

被引:25
作者
Ricciutelli, Massimo
Di Martino, Piera
Barboni, Luciano
Martelli, Sante
机构
[1] Dept Chem Sci, Lab Pharmaceut Technol, I-62032 Camerino, Italy
[2] Dept Chem Sci, Lab HPLCl, I-62032 Camerino, Italy
[3] Dept Chem Sci, Organ Chem Lab, I-62032 Camerino, Italy
关键词
rapamycin; stability; HPLC; NMR;
D O I
10.1016/j.jpba.2006.02.009
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Rapamycin or sirolimus is a carboxylic lactone-lactam macrolide with a potent immunosuppressive activity. It can be successfully used to impregnate stents inserted in coronary arteries during surgical applications, preventing fatal infection and rejection adverse effect. The chemical stability of rapamycin in several organic-volatile solvents (acetone, chloroform, dichloromethane, hexane, ethyl alcohol, ethyl acetate, methyl alcohol, pentane and tetrahydrofurane) was established by HPLC-DAD-MS in reverse phase analysis. Results permitted to exclude rapamycin chemical degradation and to reveal a typical chemical isomerization, favoured in accordance to the solvent used. Two typical peaks appear, denominated beta and gamma, the time retention of which are, respectively, 11.3 and 15.0 min. Thanks to data recovered by NMR, spectrophotometric UV and mass analyses, it was possible to establish that both peaks correspond to two different isomeric forms of rapamycin. In addition, it was possible to establish that the relative percentage peak area varies according to the solvent and to the experimental time. The two isomeric forms are in equilibrium and each solvent concurs to differently displace this equilibrium versus one form rather than another, according to their both polarity index and aproticity. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:1070 / 1074
页数:5
相关论文
共 19 条
  • [1] Fatal infection after rapamycin eluting coronary stent implantation
    Alfonso, F
    Moreno, R
    Vergas, J
    [J]. HEART, 2005, 91 (06) : e51
  • [2] 2 DISTINCT SIGNAL TRANSMISSION PATHWAYS IN LYMPHOCYTES-T ARE INHIBITED BY COMPLEXES FORMED BETWEEN AN IMMUNOPHILIN AND EITHER FK506 OR RAPAMYCIN
    BIERER, BE
    MATTILA, PS
    STANDAERT, RF
    HERZENBERG, LA
    BURAKOFF, SJ
    CRABTREE, G
    SCHREIBER, SL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (23) : 9231 - 9235
  • [3] BLAZAR BR, 1994, BLOOD, V83, P600
  • [4] DUMONT FJ, 1990, J IMMUNOL, V144, P251
  • [5] ON THE CHEMISTRY AND HIGH-FIELD NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY OF RAPAMYCIN
    FINDLAY, JA
    RADICS, L
    [J]. CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 1980, 58 (06): : 579 - 590
  • [6] HELDMAN AW, 2001, CIRCULATION, V12, P513
  • [7] THE ISOLATION, SYNTHESIS AND CHARACTERIZATION OF AN ISOMERIC FORM OF RAPAMYCIN
    HUGHES, P
    MUSSER, J
    CONKLIN, M
    RUSSO, R
    [J]. TETRAHEDRON LETTERS, 1992, 33 (33) : 4739 - 4742
  • [8] SYNERGISTIC INTERACTIONS OF CYCLOSPORINE AND RAPAMYCIN TO INHIBIT IMMUNE PERFORMANCES OF NORMAL HUMAN PERIPHERAL-BLOOD LYMPHOCYTES INVITRO
    KAHAN, BD
    GIBBONS, S
    TEJPAL, N
    STEPKOWSKI, SM
    CHOU, TC
    [J]. TRANSPLANTATION, 1991, 51 (01) : 232 - 239
  • [9] STRUCTURE OF RAPAMYCIN - AN NMR AND MOLECULAR-DYNAMICS INVESTIGATION
    KESSLER, H
    HAESSNER, R
    SCHULER, W
    [J]. HELVETICA CHIMICA ACTA, 1993, 76 (01) : 117 - 130
  • [10] INHIBITION OF IMMUNE-RESPONSE BY RAPAMYCIN, A NEW ANTIFUNGAL ANTIBIOTIC
    MARTEL, RR
    KLICIUS, J
    GALET, S
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1977, 55 (01) : 48 - 51